Nanjing Gaoke Company Limited

Shanghai Stock Exchange 600064.SS

Nanjing Gaoke Company Limited EBITDA for the year ending December 31, 2023: USD 237.59 M

Nanjing Gaoke Company Limited EBITDA is USD 237.59 M for the year ending December 31, 2023, a -43.92% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • Nanjing Gaoke Company Limited EBITDA for the year ending December 31, 2022 was USD 423.68 M, a -6.95% change year over year.
  • Nanjing Gaoke Company Limited EBITDA for the year ending December 31, 2021 was USD 455.30 M, a 49.54% change year over year.
  • Nanjing Gaoke Company Limited EBITDA for the year ending December 31, 2020 was USD 304.47 M, a 15.74% change year over year.
  • Nanjing Gaoke Company Limited EBITDA for the year ending December 31, 2019 was USD 263.06 M, a 21.04% change year over year.
Key data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)
Market news
Loading...
Shanghai Stock Exchange: 600064.SS

Nanjing Gaoke Company Limited

CEO Mr. Yang Jun Lu
IPO Date May 6, 1997
Location China
Headquarters Hi-Tech Center
Employees 508
Sector Industrials
Industries
Description

Nanjing Gaoke Company Limited develops real estate properties in China. The company develops and sells commercial residential properties; and undertakes renovation of old communities, new roads, and mountain park construction projects. It also offers house construction, municipal engineering construction and supervision, landscaping construction and maintenance, sewage treatment, and water supply services; and property management, land development, engineering design, and environmental protection project construction services. In addition, the company is involved in the industrial investment, venture capital, securities, investment management, consulting, and other investment activities; and provision of financing services for small and medium-sized technology companies, and start entrepreneurship. Further, it engages in the production and sale of various Chinese and Western medicine preparations; medical and health care consulting and service activities; and provision of leasing houses. The company was founded in 1992 and is based in Nanjing, China.

Similar companies

600060.SS

Hisense Visual Technology Co., Ltd.

USD 2.79

2.92%

600058.SS

Minmetals Development Co., Ltd.

USD 0.95

1.76%

600007.SS

China World Trade Center Co., Ltd.

USD 3.20

0.78%

600062.SS

China Resources Double-Crane Pharmaceutical Co.,Ltd.

USD 2.64

2.39%

StockViz Staff

January 15, 2025

Any question? Send us an email